arrow
P

Paul Gissen

university college london
H-index:62
Citation Count:1.4万
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Longitudinal outcomes of non-transplanted ornithine transcarbamylase deficiency in males and females: a multicentre UK natural history cohort

非移植鸟氨酸转氨甲酰酶缺乏症在男性和女性中的纵向结局:一项多中心英国自然病史队列研究

2026-07-280
OA
Identification of AAV Vector Integration Sites in Primary Human and Macaque Hepatocytes in vivo, and Analysis of Oncogenic Risk

体内鉴定人源和食蟹猴原代肝细胞中AAV载体整合位点及分析致癌风险

2026-07-220
OA
Safety and efficacy analysis of in vivo lentiviral gene therapy in pre-clinical ARC syndrome models

在ARC综合征动物模型中体内慢病毒基因治疗的安全性与有效性分析

2026-06-190
OAAI
A roadmap for a patient-centred approach to Pompe disease management

针对庞贝病管理的以患者为中心的方法路线图

2026-02-140
OAAI
Pilot Study of Fingolimod Treatment in Neuronal Ceroid Lipofuscinosis Type 1

苯丁酸甘油酯治疗神经元蜡样脂褐质沉积症1型的初步研究

2026-02-010
PRE
From Neonatal Encephalopathy to Adult Survival: Revisiting the Natural History of D-Bifunctional Protein Deficiency in a Multicentre International Case Series

从新生儿脑病到成人存活:多中心国际病例系列中重新审视D-双功能蛋白缺乏的自然史

2025-12-090
PRE
Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom

英国家庭中CLN2和CLN3巴顿病对家庭影响的证据

2025-05-120
OA
Long-term findings of N-acetyl-L-leucine for Niemann-Pick disease type C
2025-02-010
PRE
Clinical Features, Biochemistry, Imaging, and Treatment Response in a Single-Center Cohort With Coenzyme Q10 Biosynthesis Disorders
2024-12-011
PRE
Macrophage Inhibitor Clodronate Enhances Liver Transduction of Lentiviral but Not Adeno-Associated Viral Vectors or mRNA Lipid Nanoparticles in Neonatal and Juvenile Mice

巨噬细胞抑制剂氯膦酸钠增强新生和幼年小鼠慢病毒而不是腺相关病毒载体或mRNA脂质纳米颗粒的肝脏转导

CELLS
IF5.2
2024-11-290
OAAI
Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy

慢病毒基因治疗脑型肾上腺脑白质营养不良

2024-10-104
PRE
Evolution of Movement Disorders in Patients With CLN2-Batten Disease Treated With Enzyme Replacement Therapy
2024-08-133
PRE
Enzyme Replacement Therapy for CLN2 Disease: MRI Volumetry Shows Significantly Slower Volume Loss Compared with a Natural History Cohort
2024-07-082
PRE
Trial of N-Acetyl-L-Leucine in Niemann-Pick Disease Type C
2024-02-018
PRE
RGX-381: Interim results from the first-in-human clinical trial of an investigational gene therapy for the treatment of ocular manifestations of CLN2 Batten disease
2024-02-010
PRE
Cerliponase alfa for the treatment of CLN2 disease in a patient cohort including children under 3 years of age
2024-02-010
PRE
Results of a phase III, randomized, placebo-controlled crossover trial with N-acetyl-L-leucine for Niemann-Pick disease type C
2024-02-010
PRE
mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria
2024-01-108
OAAI